CUL4A (Cullin-4A) is a member of the cullin family of scaffold proteins that form the core of Cullin-RING E3 ubiquitin ligase (CRL) complexes. These multiprotein assemblies are essential for targeted protein degradation through the ubiquitin-proteasome system (UPS), which regulates nearly all cellular processes including cell cycle progression, DNA damage repair, transcription, and protein quality control. CUL4A is uniquely involved in numerous neurological disorders, including Alzheimer's disease, Parkinson's disease, and Cockayne syndrome, making it a significant protein in neurodegeneration research.
Protein Name
Cullin-4A (CUL4A)
Gene
[CUL4A](/genes/cul4a)
Molecular Weight
~190 kDa
Subcellular Localization
Cytoplasm, Nucleus
Protein Family
Cullin family
Tissue Expression
Broad (brain, liver, lung, heart)
¶ Structure and Architecture
¶ Domain Organization
CUL4A contains several distinct structural domains that enable its function as a molecular scaffold:
- N-terminal Domain: Binds to the substrate recognition receptor DDB1 (DNA Damage Binding Protein 1), which recruits specific substrates for ubiquitination
- Cullin Repeat Domain (CR): Five repeat motifs that form the elongated helical scaffold structure
- C-terminal Domain: Contains the RING finger motif that recruits the E2 ubiquitin-conjugating enzyme
The CRL4 (Cullin 4-RING ligase) complex consists of:
- CUL4A: The central scaffold
- DDB1: The adaptor protein that binds to the N-terminus
- DCAF (DDB1-CUL4-associated factor): Substrate receptors that recognize specific target proteins
- RBX1/ROC1: The RING finger protein that brings the E2 enzyme close to the substrate
This modular architecture allows for remarkable substrate diversity, with over 300 different DCAFs identified in humans.
The UPS is the primary cellular system for targeted protein degradation:
- Ubiquitination: CUL4A CRLs catalyze the attachment of ubiquitin chains to specific substrate proteins
- Polyubiquitination: Chains of ubiquitin (typically K48-linked) mark proteins for degradation
- Proteasomal Recognition: The 26S proteasome recognizes polyubiquitinated proteins and degrades them
CUL4A plays critical roles in maintaining genomic integrity:
- Nucleotide Excision Repair (NER): CRL4^DDB2 complex recognizes and repairs UV-induced DNA damage
- Chromatin Remodeling: Regulates histone modifications and DNA repair factor accessibility
- Cell Cycle Checkpoints: Controls checkpoint proteins to ensure DNA integrity before division
CUL4A CRLs regulate transcription factors and co-factors:
- Control of steroid hormone receptors
- Regulation of circadian clock proteins
- Modulation of inflammatory response factors
CUL4A dysfunction contributes to AD pathogenesis through multiple mechanisms:
- Impaired Protein Clearance: The UPS is compromised in AD brains, and CUL4A dysfunction exacerbates this defect
- DNA Damage Accumulation: Neurons in AD show increased DNA damage; CUL4A deficiency impairs repair mechanisms
- Tau Pathology: CUL4A regulates tau ubiquitination and clearance; dysregulation contributes to NFT formation
- Amyloid-β Metabolism: CRL4 complexes influence amyloid precursor protein (APP) processing
In PD, CUL4A involvement includes:
- α-Synuclein Clearance: Impaired ubiquitination may affect clearance of toxic α-synuclein aggregates
- Mitochondrial Quality Control: CUL4A regulates proteins involved in mitochondrial dynamics
- Dopaminergic Neuron Vulnerability: DNA repair deficits in dopaminergic neurons may be CUL4A-related
Cockayne syndrome (CS) is caused by recessive mutations in CUL4A:
- Severe developmental defects including progressive neurological deterioration
- Premature aging phenotype
- Defective transcription-coupled DNA repair (TCR)
- Neurodegeneration with demyelination
CUL4A has been implicated in:
- Huntington's Disease: Altered ubiquitination of mutant huntingtin protein
- Amyotrophic Lateral Sclerosis: Dysregulation of protein clearance pathways
- Prion Diseases: UPS impairment and protein aggregate formation
CUL4A represents a potential therapeutic target:
- Modulators of CRL4 Activity: Small molecules that enhance or inhibit CUL4A ligase function
- DCAF-Specific Inhibitors: Targeting specific substrate receptors
- UPS Enhancers: Compounds that boost overall proteasome function
- CUL4A Expression Modulation: Careful balancing of CUL4A activity
- DCAF-Targeted Therapy: More specific targeting of pathological substrates
¶ Interactions and Pathways
- DDB1: Essential adaptor for CRL4 complex formation
- DDB2: DNA damage recognition factor (XPE)
- CSA: Cockayne syndrome protein A (in TCR)
- ROC1/RBX1: RING finger protein for E2 recruitment
- Ubiquitin-Proteasome System: Primary degradation pathway
- DNA Damage Response: Global and transcription-coupled repair
- p53 Pathway: CUL4A regulates p53 stability and function
- NF-κB Signaling: Control of inflammatory responses